Srdjan Marković

409 total citations
31 papers, 314 citations indexed

About

Srdjan Marković is a scholar working on Epidemiology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Srdjan Marković has authored 31 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Srdjan Marković's work include Genetic factors in colorectal cancer (5 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (4 papers). Srdjan Marković is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (4 papers). Srdjan Marković collaborates with scholars based in Serbia, United States and France. Srdjan Marković's co-authors include Daniela Bojic, Dragana Kastratović, Vitomir S. Konstantinović, Nadine Spielmann, David Akin, O Brinkmann, Milovan Dimitrijević, Hui Zhou, Vladimir Nešić and David T. Wong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oral Oncology and Journal of Crohn s and Colitis.

In The Last Decade

Srdjan Marković

28 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srdjan Marković Serbia 9 80 69 65 62 54 31 314
Marni Stott‐Miller United States 14 33 0.4× 162 2.3× 41 0.6× 76 1.2× 45 0.8× 24 589
Cristina Martínez‐Reglero Spain 11 29 0.4× 87 1.3× 16 0.2× 43 0.7× 34 0.6× 30 294
Carolin Pütter Germany 12 53 0.7× 92 1.3× 8 0.1× 55 0.9× 7 0.1× 24 398
M. Lombardo Italy 9 67 0.8× 49 0.7× 14 0.2× 28 0.5× 7 0.1× 35 453
Maddalena Giuliani Italy 14 22 0.3× 60 0.9× 5 0.1× 37 0.6× 53 1.0× 22 622
Yen‐Chun Liu Taiwan 10 22 0.3× 59 0.9× 18 0.3× 11 0.2× 11 0.2× 25 311
Stefania Vecchio Italy 10 66 0.8× 72 1.0× 8 0.1× 132 2.1× 232 4.3× 28 440
Shaoyan Feng China 13 107 1.3× 118 1.7× 3 0.0× 100 1.6× 93 1.7× 30 463
P. Delvecchio United States 8 23 0.3× 64 0.9× 6 0.1× 42 0.7× 37 0.7× 15 301
Prithvi Singh India 14 41 0.5× 284 4.1× 7 0.1× 17 0.3× 9 0.2× 44 537

Countries citing papers authored by Srdjan Marković

Since Specialization
Citations

This map shows the geographic impact of Srdjan Marković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srdjan Marković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srdjan Marković more than expected).

Fields of papers citing papers by Srdjan Marković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srdjan Marković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srdjan Marković. The network helps show where Srdjan Marković may publish in the future.

Co-authorship network of co-authors of Srdjan Marković

This figure shows the co-authorship network connecting the top 25 collaborators of Srdjan Marković. A scholar is included among the top collaborators of Srdjan Marković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srdjan Marković. Srdjan Marković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marković, Srdjan, et al.. (2025). Telehealth—An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease. Medicina. 61(2). 332–332. 1 indexed citations
3.
Honap, Sailish, et al.. (2025). Building a healthcare data warehouse: considerations, opportunities, and challenges. Frontiers in Digital Health. 7. 1691142–1691142.
4.
Perović, Milan, et al.. (2025). Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study. Biomedicines. 13(8). 1928–1928. 1 indexed citations
5.
Čolak, Emina, et al.. (2024). Patient blood management: Team working between clinical transfusiology and clinical pharmacology. SHILAP Revista de lepidopterología. 11(2). 1456–1461. 1 indexed citations
7.
Marković, Srdjan, et al.. (2023). P704 The effect of antiTNFα and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease. Journal of Crohn s and Colitis. 17(Supplement_1). i837–i837. 2 indexed citations
8.
Knežević, Tamara, et al.. (2022). P330 Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination. Journal of Crohn s and Colitis. 16(Supplement_1). i349–i349. 1 indexed citations
9.
Marković, Srdjan, et al.. (2021). Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series. Cureus. 13(10). e19019–e19019. 1 indexed citations
10.
Jonaitis, Laimas Virginijus, Srdjan Marković, Klaudia Farkas, et al.. (2021). Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective. BMC Proceedings. 15(S17). 25–25. 42 indexed citations
11.
Protić, Marijana, Srdjan Marković, & Dino Tarabar. (2017). Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem. Digestive Diseases. 35(1-2). 134–138. 2 indexed citations
12.
Marković, Srdjan, et al.. (2016). Current trends in clinical genetics of colorectal cancer.. PubMed. 21(5). 1042–1049. 6 indexed citations
13.
Marković, Srdjan, et al.. (2016). Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. The Indian Journal of Medical Research. 143(Suppl 1). S104–S111. 10 indexed citations
14.
Vuković, Mira, Branislav Gvozdenović, Bryan P. McCormick, et al.. (2015). Can Didactic Continuing Education Improve Clinical Decision Making and Reduce Cost of Quality? Evidence From a Case Study. Journal of Continuing Education in the Health Professions. 35(2). 109–118. 15 indexed citations
15.
Marković, Srdjan, et al.. (2012). Serotonergic organization of the central nervous system.. PubMed. 24 Suppl 3. S326–30. 6 indexed citations
16.
Krivokapić, Zoran, et al.. (2012). Clinical and pathological tools for identifying microsatellite instability in colorectal cancer. Croatian Medical Journal. 53(4). 328–335. 2 indexed citations
17.
Marković, Srdjan, et al.. (2011). High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer. Journal of Molecular Histology. 43(2). 137–143. 6 indexed citations
18.
Bojic, Daniela & Srdjan Marković. (2011). Terminal ileitis is not always Crohn's disease.. PubMed. 24(4). 271–275. 33 indexed citations
19.
Brinkmann, O, Dragana Kastratović, Milovan Dimitrijević, et al.. (2010). Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncology. 47(1). 51–55. 128 indexed citations
20.
Kastratović, Dragana, Zorana Vasiljević, Mihajlo Spasić, et al.. (2007). Carvedilol Increases Copper‐Zinc Superoxide Dismutase Activity in Patients with Acute Myocardial Infarction. Basic & Clinical Pharmacology & Toxicology. 101(2). 138–142. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026